Our co-convenors

  • Davina Ghersi (NHMRC Clinical Trials Centre, University of Sydney, Australia; and NHMRC, Canberra, Australia)
  • Jesse Berlin (Johnson & Johnson Pharmaceutical Research & Development, LLC, USA)
  • Lisa Askie (NHMRC Clinical Trials Centre, University of Sydney, Australia)